Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-04 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.070 | -0.070 | 0.0000 | ||||
REV | 7.960M | 7.788M | -172.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
TTOO | T2 Biosystems | 1.60 | -0.35 | -17.95% | 236.7M |
You can purchase shares of T2 Biosystems (NASDAQ: TTOO) through any online brokerage.
Other companies in T2 Biosystems’s space includes: Kezar Life Sciences (NASDAQ:KZR), Cabaletta Bio (NASDAQ:CABA) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for T2 Biosystems (NASDAQ: TTOO) was reported by Alliance Global Partners on 2021-01-27. The analyst firm set a price target for 2.40 expecting TTOO to rise to within 12 months (a possible 50.00% upside). 8 analyst firms have reported ratings in the last year.
The stock price for T2 Biosystems (NASDAQ: TTOO) is $1.6 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for T2 Biosystems.
There is no upcoming split for T2 Biosystems.